Publicacions en col·laboració amb investigadors/es de Centro de Investigación Médica Aplicada (57)

2024

  1. Genetically inferred birthweight, height, and puberty timing and risk of osteosarcoma

    Cancer Epidemiology, Vol. 92

2023

  1. Correction: The phospholipid transporter PITPNC1 links KRAS to MYC to prevent autophagy in lung and pancreatic cancer (Molecular Cancer, (2023), 22, 1, (86), 10.1186/s12943-023-01788-w)

    Molecular Cancer

  2. Cpt1c Downregulation Causes Plasma Membrane Remodelling and Anthracycline Resistance in Breast Cancer

    International Journal of Molecular Sciences, Vol. 24, Núm. 2

  3. ENPP1 Immunobiology as a Therapeutic Target

    Clinical cancer research : an official journal of the American Association for Cancer Research, Vol. 29, Núm. 12, pp. 2184-2193

  4. The phospholipid transporter PITPNC1 links KRAS to MYC to prevent autophagy in lung and pancreatic cancer

    Molecular Cancer, Vol. 22, Núm. 1

2022

  1. Complement C5a induces the formation of neutrophil extracellular traps by myeloid-derived suppressor cells to promote metastasis

    Cancer Letters, Vol. 529, pp. 70-84

  2. Design and validation of a tunable inertial microfluidic system for the efficient enrichment of circulating tumor cells in blood

    Bioengineering and Translational Medicine, Vol. 7, Núm. 3

  3. Genomic and proteomic profiling of osteosarcoma

    Bone Cancer: Bone Sarcomas and Bone Metastases - From Bench to Bedside (Elsevier), pp. 591-604

2020

  1. Combinatorial nanomedicine made of squalenoyl-gemcitabine and edelfosine for the treatment of osteosarcoma

    Cancers, Vol. 12, Núm. 7, pp. 1-13

  2. Frequency of Pathogenic Germline Variants in Cancer-Susceptibility Genes in Patients with Osteosarcoma

    JAMA Oncology, Vol. 6, Núm. 5, pp. 724-734

  3. Sarcoma treatment in the era of molecular medicine

    EMBO Molecular Medicine, Vol. 12, Núm. 11

  4. Short-term starvation reduces IGF-1 levels to sensitize lung tumors to PD-1 immune checkpoint blockade

    Nature cancer, Vol. 1, Núm. 1, pp. 75-85

  5. The Mir181ab1 cluster promotes KRAS-driven oncogenesis and progression in lung and pancreas

    Journal of Clinical Investigation, Vol. 130, Núm. 4, pp. 1879-1895

  6. Wnt signaling and Loxl2 promote aggressive osteosarcoma

    Cell Research, Vol. 30, Núm. 10, pp. 885-901

2019

  1. CYR61 triggers osteosarcoma metastatic spreading via an IGF1Rβ-dependent EMT-like process

    BMC Cancer, Vol. 19, Núm. 1

  2. Complement in metastasis: A comp in the camp

    Frontiers in Immunology, Vol. 10, Núm. APR

  3. Long-term results of Perioperative High Dose Rate Brachytherapy (PHDRB) and external beam radiation in adult patients with soft tissue sarcomas of the extremities and the superficial trunk: Final results of a prospective controlled study

    Radiotherapy and Oncology, Vol. 135, pp. 91-99

  4. YES1 drives lung cancer growth and progression and predicts sensitivity to dasatinib

    American Journal of Respiratory and Critical Care Medicine, Vol. 200, Núm. 7, pp. 888-899

2018

  1. Blockade of the complement C5a/C5aR1 axis impairs lung cancer bone metastasis by CXCL16-mediated effects

    American Journal of Respiratory and Critical Care Medicine, Vol. 197, Núm. 9, pp. 1164-1176

  2. Erratum: Perioperative high-dose-rate brachytherapy in locally advanced and recurrent gynecological cancer: Final results of a Phase II trial (Brachytherapy (2018) 17(5) (734–741), (S1538472118300898) (10.1016/j.brachy.2018.04.007))

    Brachytherapy